Advertisements

Furaderm 0.2%

Quick links to important sections

Furaderm 0.2%

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Furaderm 0.2%

Property Description
Active ingredient Nitrofural (or Nitrofurazone)
Form Topical Ointment (or Cream/Solution)
Pharmacological class Synthetic Antibacterial Agent / Nitrofuran Derivative
Common purpose Local anti-infective activity on the skin
Origin Synthetic compound

Identity, Classification, and Origin

Furaderm 0.2% is a topical pharmaceutical preparation whose identity is rooted in the synthetic compound Nitrofural, also recognized by its generic name, Nitrofurazone. It is formally classified as a synthetic antibacterial drug and belongs to the Nitrofuran derivative class of antimicrobial agents. The compound is widely clinically recognized for its enduring stability and effectiveness as a localized agent.

This medicine is designated as a topical anti-infective agent because its intended route of administration is confined to the skin's surface. Its efficacy against a wide spectrum of bacteria has been established in its use as a topical microbicide.


Composition and Form of the Preparation

The composition of Furaderm 0.2% establishes it as a single-active ingredient product where Nitrofural is precisely incorporated at a concentration of 0.2%. This formula is typically delivered as a topical ointment or a related cutaneous preparation, providing an easy-to-apply base.

The preparation consists of the active ingredient and an appropriate pharmaceutical vehicle, such as an oleaginous or emulsified base, which ensures the medicine can be retained on the skin for an extended duration. This formulation utilizes an organic Nitrofuran derivative, a distinct chemical mechanism that has been the subject of continuous antimicrobial research and development.


General Purpose: Antimicrobial Action on the Skin

The general purpose of Furaderm 0.2% is to provide powerful, localized broad-spectrum antimicrobial activity to manage the presence of susceptible microorganisms on the skin's surface. Its action is primarily bactericidal, meaning it actively kills target bacteria rather than merely inhibiting their growth, a key characteristic of its profile.

This intrinsic anti-infective capability supports the maintenance of a clean, controlled environment for compromised skin. The medicine works by interfering with the bacteria's essential metabolic processes, a mechanism that has been established across the Nitrofuran class.

Advertisements

What side effects are possible with Furaderm 0.2%?

Possible Side Effects and Safety Information

The safety profile of Furaderm 0.2%, which contains the active ingredient nitrofural (nitrofurazone), is defined by officially documented adverse reactions and regulatory classifications as stated in government prescribing information.


Adverse Reaction Scope

The most frequently observed adverse reactions are local skin reactions at the application site, classified as common in regulatory documents. These are grouped under the Skin and subcutaneous tissue disorders system-organ class and may manifest as contact dermatitis, including a burning sensation, itching (pruritus), redness (erythema), or swelling. These effects are typically documented to resolve upon discontinuation of the medicine.


Systemic and Serious Safety Considerations

A potentially serious adverse reaction associated with the nitrofuran drug class is hemolytic anemia, which is classified as rare for topical use. This risk is particularly noted in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, who are documented to have an increased susceptibility to this blood and lymphatic system disorder if systemic absorption occurs.


Regulatory Safety Restrictions

Official prescribing information includes a contraindication for individuals with a known hypersensitivity to nitrofural or any component of the formulation. Furthermore, the label mandates discontinuation of the medicine if signs of pronounced irritation, sensitization, or superinfection appear at the application site.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Furaderm 0.2% (Nitrofural Topical) addresses overdose based on two distinct exposure routes. Due to the negligible systemic absorption of Nitrofural through the skin, the clinical presentation of topical over-application is generally localized. This type of overuse may lead to an intensification of local skin irritation, redness, or swelling at the application site. Regulatory documents mandate that if these local reactions persist or worsen despite discontinuing the product, medical advice must be sought to manage the persistent cutaneous symptoms.

The scenario requiring urgent medical attention is the accidental oral ingestion of the product. Swallowing the ointment can lead to systemic absorption of Nitrofural, posing a risk of systemic toxicity. Documented manifestations may include nausea, vomiting, and potential signs of central nervous system alteration.

The official emergency response requires an immediate call to a Poison Center or a doctor if the product is swallowed. Management of this systemic exposure is strictly focused on symptomatic and supportive treatment, as regulatory data confirms that no specific antidote is known for Nitrofural poisoning. Due to the potential for serious effects, hospital monitoring may be required following accidental ingestion. General safety requirements stress the importance of keeping the product out of the reach of children to prevent this type of accidental oral exposure.

Advertisements

Therapeutic Uses of Furaderm 0.2%

What Furaderm 0.2% Treats: Main Uses and Benefits

Furaderm 0.2% is commonly used in therapeutic domains where management of bacterial contamination in the skin is required.

The medication is commonly used across conditions presenting with acute or disruptive episodes, including second and third-degree burns, chronic stasis ulcers, and contamination risk at skin grafting sites. It helps address symptom clusters that may become intense or disruptive by managing the bacterial presence. The antibacterial agent is relevant across domains where additional symptomatic support is needed, particularly in managing the infection risk associated with severe skin damage. “It is relevant in situations where symptoms may become noticeable and interfere with daily functioning.” This use supports the patient during difficult episodes by easing the overall symptom burden and contributes to improved comfort during symptomatic periods, which may assist with maintaining functional stability.


Therapeutic Focus: Infection Risk Management

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Furaderm 0.2%? (Nitrofurazone Topical)

The population eligibility for Furaderm 0.2% (Nitrofurazone Topical) is defined by official regulatory documentation, focusing on hypersensitivity, age, and physiological status. The most definitive restriction is an absolute contraindication for individuals with a known prior sensitization or history of allergy to nitrofurazone.

Population Status Regulatory Classification
Absolute Prohibition Contraindicated in patients with known prior sensitization to nitrofurazone.
Conditional Use Caution is required in patients with known or suspected renal impairment due to the risk of excipient absorption in certain topical formulations.
Use Not Established Pregnant patients and nursing mothers; safe use has not been established and is generally not recommended unless therapeutic benefit outweighs risk.

Age-Group Eligibility: Use in adults is established for the approved indications. For children (pediatric use), specific safety and dose must be determined by a healthcare provider, as specific comparative data are lacking. No specific comparative information is available regarding use in older adults (geriatric patients).

Advertisements

What should I know about interactions with other medicines?

The interaction profile for Furaderm 0.2% (Nitrofural) is highly specific and limited, reflecting its topical route of administration and minimal systemic absorption, according to government regulatory information.

Localized Chemical Incompatibility

The only formally documented interaction involves a localized chemical incompatibility with certain medicinal products. This is observed with ester-type local anesthetics that are derivatives of para-aminobenzoic acid (PABA), such as Procaine. Official regulatory statements specify that Nitrofural can directly counteract the action of these anesthetics, leading to their inactivation at the application site. This interaction is a restriction where simultaneous topical co-administration on the same area is avoided.

Interaction Category Specific Product Class Official Outcome
Chemical Incompatibility PABA-derivative local anesthetics (e.g., Procaine) Inactivation of the anesthetic

Systemic Interactions and Restrictions

The regulatory documentation for the topical preparation does not define any systemic drug-drug interactions. As a result, no formal pharmacokinetic interactions (such as those involving CYP-enzymes or drug transporters), no pharmacodynamic interactions, and no interactions with food, alcohol, or herbal products are specified in official government labeling. No mandatory time separation rules are documented for co-administration with systemic medicines.

Advertisements

Mechanism of Action

The action of Nitrofural (Nitrofurazone) is initiated when the drug, acting as a prodrug, is taken up by the bacterial cell. Specific bacterial enzymes, known as nitroreductases, are required to chemically reduce the drug's nitro group ( -NO2), converting the compound into highly reactive and toxic electrophilic intermediates. This mechanism ensures the prodrug is primarily activated by bacterial nitroreductases within the microbial cell.

Once activated, these highly unstable intermediates non-selectively attack and covalently modify multiple essential components within the bacterial cell. Key targets include the organism's genetic material (DNA/RNA) and vital metabolic enzymes required for energy production (ATP). This multi-pronged chemical damage simultaneously inhibits the bacteria's ability to replicate, repair, and sustain energy, forming a lethal cascade.

The compound effect of inhibiting both biosynthesis and energy metabolism results in the failure of the bacterial cell's life processes. This direct assault produces a bactericidal effect—meaning the drug actively kills the susceptible target microorganisms—which is the fundamental physiological consequence of the cellular kill rate. The mechanism's reliance on bacterial nitroreductase activity is also its main limitation, as bacteria with reduced enzyme function may exhibit resistance.

Advertisements

Dosage and Administration Information

This information outlines the administration instructions for Furaderm 0.2% (a topical product).

Administration Guidelines

Guideline Area Instruction
Route of Administration Topical (Cutaneous use) only
Dosage Form Cream or Ointment (20 mg/g concentration)
Frequency Apply three or four times daily
Duration Treatment is typically 7 to 14 days, but generally should not exceed 10 days without medical review

Procedural Steps

  1. Hand Preparation: Always wash hands thoroughly before and after applying the cream or ointment.
  2. Application: Apply a small amount or a thin layer of the product gently to the affected skin lesion.
  3. Covered Lesions: If the affected area is to be covered with a sterile dressing or gauze, less frequent applications (e.g., once or twice daily) may be adequate.
  4. Avoidance: Care must be taken to avoid contact with the eyes and mucous membranes, especially when applying to the face.

Special Instructions

  • Missed Dose: If a dose is forgotten, the instruction is to apply the usual amount as soon as remembered and then continue the regular schedule; do not apply a double dose to compensate.
  • Course Completion: The full prescribed course of therapy must be completed as directed by the healthcare provider.
  • Pediatric Use: The frequency and dosing regimen for adults and children (including infants) are generally the same.

These instructions define the topical application method, the daily frequency, and the maximum recommended duration for use for the medicine.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Furaderm 0.2%

The research base for Furaderm 0.2% (Nitrofural) is rooted in its long history as a topical antibacterial agent. The evidence is drawn from older comparative trials, established clinical experience, and more recent Randomized Clinical Trials (RCTs) that often examine specific, short-term outcomes related to wound management. The following overview outlines the types of research conducted, the focus of the studies, and the areas where evidence remains uncertain.


Evidence for Use in Second and Third-Degree Burns

Research exploring the use of Nitrofural 0.2% in studies evaluating burns has primarily focused on adult patients with second and third-degree injuries. This research examined measures such as the epithelialization rate and total healing time (outcomes related to physical discomfort), and monitored whether wound infection status changed in the observed populations. Findings described patterns related to healing timeframes; comparative trials explored different outcomes when Nitrofural 0.2% was examined alongside other topical agents or treatments.

The available evidence has limitations. Research exploring long-term outcomes, such as scarring or functional results extending beyond the initial healing phase, are not well characterized in public regulatory summaries. Furthermore, much of the foundational evidence involves older trials, and comparative evidence against contemporary, first-line antimicrobial treatments is limited.


Evidence for Managing Contamination Risk at Skin Grafting Sites

Research for this application is drawn from historical clinical use data, regulatory summaries, and studies focused on microbiological activity of the compound. The outcomes examined relate to the status of bacterial contamination at both the donor and recipient sites and the subsequent graft outcome following the procedure. Regulatory reviews described the established clinical patterns of use concerning managing bacterial contamination in the immediate post-operative phase.

Specific, large-scale human RCT data comparing Nitrofural 0.2% directly against other modern antimicrobial dressings for the specialized endpoint of reducing graft rejection is limited in public regulatory evidence summaries. Evidence quality varies across studies, and this application relies largely on the drug’s established clinical role.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Furaderm 0.2% (FAQ)


Q: Can Furaderm 0.2% be used on sensitive skin areas?

Official information indicates this product should not contact the eyes or mucous membranes. Regulatory labeling specifies that discontinuation of the medicine is required if signs of pronounced irritation, sensitization, or swelling appear, as these can be signs of a local reaction or hypersensitivity.


Q: Is a prescription always required for Furaderm 0.2%?

According to regulatory documents, this medicine is available for human use only with a doctor's prescription. It is classified as a prescription-only medicine and is not available as an over-the-counter product.


Q: Are there any common interactions between Furaderm 0.2% and makeup or skincare products?

Regulatory documentation does not list formal interactions with general cosmetic products, food, or alcohol. The only documented local chemical incompatibility is with a specific class of products: PABA-derivative local anesthetics (like procaine).


Q: Can Furaderm 0.2% be used for acne or just for other skin conditions?

The regulatory indications for this product are for use with second and third-degree burns and for managing contamination risks at skin grafting sites. It is not explicitly indicated for the treatment of acne.


Q: Does sun exposure matter when using Furaderm 0.2%?

Yes, official guidance advises that the product must be protected from light and direct sunlight during storage. Some regulatory guidance also advises caution regarding exposure to direct sunlight while the product is in use.


Q: Is Furaderm 0.2% safe to use during pregnancy or while breastfeeding?

Official regulatory documents state that safe use during pregnancy or while breastfeeding has not been established. It is generally not recommended unless the therapeutic benefit to the patient is considered to clearly outweigh the potential risk, as safe use has not been established.


Q: What's the best way to store Furaderm 0.2% cream?

The product should be stored at controlled room temperature, typically between 20 C and 25 C. Regulatory documents specify that the product should be kept away from direct sunlight, protected from light, and kept from freezing to maintain its stability.


Q: What are the inactive ingredients in Furaderm 0.2%?

The product is a single-active ingredient formulation containing Nitrofural, which is combined with a pharmaceutical vehicle or base. This base ensures the medicine can be applied and retained on the skin. Specific inactive ingredients, such as polyethylene glycols in some formulations, are listed on the official product label.


Q: Can Furaderm 0.2% be used on the scalp or in the hair?

Furaderm 0.2% is for topical use on the affected skin lesion. Although it can be applied to compromised skin areas, official administration instructions specify that contact with mucous membranes should be avoided.


Q: How does the mechanism of action of Furaderm 0.2% prevent skin problems?

The medicine works by being activated by bacterial enzymes inside the microorganism, which creates toxic intermediates. These intermediates then attack the bacteria's vital components, leading to a bactericidal effect. By actively killing susceptible target bacteria, it helps manage the presence of microorganisms on the skin.


Q: Are there any foods or supplements that interact with topical Furaderm 0.2%?

Official regulatory documentation for the topical preparation does not specify any formal interactions with food, alcohol, or herbal products.


Q: When should I stop using Furaderm 0.2%?

Regulatory documentation advises that the medicine should be stopped upon completion of the full prescribed course of therapy, even if symptoms have improved. Official labeling also mandates immediate discontinuation if signs of pronounced irritation, sensitization, or a new infection appear at the application site.


Q: Can I use other topical products like moisturizers at the same time as Furaderm 0.2%?

The only formal incompatibility documented is with PABA-derivative local anesthetics. For other topical products like moisturizers, co-administration on the same area should be avoided unless specified by a healthcare provider.


Q: What type of skin conditions has Furaderm 0.2% been clinically tested for?

The clinical evidence base and indications for this medicine are focused on its use as adjunctive therapy for patients with second and third-degree burns, and for managing contamination risks associated with skin grafting sites.


Q: Is it possible to be allergic to Furaderm 0.2%?

Yes, official product information lists a contraindication for individuals with a known prior hypersensitivity (allergy) to the active ingredient, nitrofural, or any other component used in the formulation.


Q: What's the difference in usage for Furaderm 0.2% cream versus an ointment?

The regulatory documents state that the standard frequency and general dosing regimen are typically the same for both the cream and ointment forms. However, some formulations of the ointment may contain excipients that are a point of caution for use in patients with renal impairment.


Q: Does Furaderm 0.2% have any systemic (body-wide) side effects?

The most frequent adverse reactions are local skin reactions. However, a potentially serious but rare systemic side effect noted for the drug class is hemolytic anemia. This risk is primarily associated with individuals who have a G6PD deficiency, should sufficient systemic absorption occur.


Q: Why might a patient be asked to use Furaderm 0.2% intermittently rather than every day?

The application frequency may be reduced if the affected area is covered. Regulatory guidelines note that if a sterile dressing or gauze is applied, less frequent applications (such as once daily) may be adequate compared to when the area is left uncovered.


Q: Can older adults use Furaderm 0.2% safely?

Official regulatory documentation states that there is no specific information comparing the use of this product in older adults with its use in other age groups, as clinical studies have generally been done on adult patients.


Q: Is it necessary to cover the treated area after applying Furaderm 0.2%?

It is not mandatory to cover the area. However, if the area is covered with a sterile dressing, the healthcare provider may adjust the application frequency, as less frequent application may be adequate.


Q: Can Furaderm 0.2% be used on broken skin or open wounds?

The product is indicated for compromised skin areas like burns and skin graft sites. However, official warnings caution that certain excipients in some formulations may be absorbed through large areas of broken or denuded skin, which is a caution point for use in patients with renal impairment.


Q: Does the efficacy of Furaderm 0.2% decrease over time with prolonged use?

Official warnings note that prolonged use of the medicine may allow the overgrowth of non-susceptible organisms, including fungi, which can reduce the product’s overall effectiveness. Treatment should not exceed the recommended duration without medical review.


Q: What's the purpose of the base ingredients in the Furaderm 0.2% cream formulation?

The purpose of the base (or vehicle) is to provide an easy-to-apply structure that ensures the active ingredient is retained on the skin for the necessary duration. Additionally, some base ingredients may present a caution point, such as potential absorption through denuded skin in patients with renal impairment.


Q: Does Furaderm 0.2% treat the underlying cause or just the symptoms?

The product is classified as a bactericidal agent, meaning its primary action is to actively kill the susceptible bacteria. This addresses the underlying microbial cause of the infection rather than just masking the symptoms.


Q: Can I use Furaderm 0.2% if I have other chronic health issues?

Regulatory documents list renal impairment as a condition requiring caution due to the potential for excipient absorption in some topical formulations. There is also an increased risk of a rare side effect (hemolytic anemia) in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, should systemic absorption occur.


Q: Can Furaderm 0.2% be used on the face?

The product can be used on the face, but official administration instructions specify that contact with the eyes and mucous membranes should be strictly avoided.


Q: Does applying too much Furaderm 0.2% increase the risk of side effects?

Administration guidelines recommend applying only a small amount or a thin layer. Applying the product to large areas of broken skin or under occlusive dressings may increase the risk of systemic absorption and associated rare side effects, such as hemolytic anemia.


Q: Is it normal to feel a slight burning sensation when I first apply Furaderm 0.2%?

Yes, a slight burning sensation at the application site is listed as one of the common local skin reactions in the official adverse reaction scope. These effects are generally documented to resolve upon discontinuation of the medicine.


Q: For how long is it generally safe to use Furaderm 0.2% continuously?

The typical duration of treatment is 7 to 14 days, and use should generally not exceed 10 days without a medical review. Prolonged use should be avoided due to the potential for overgrowth of non-susceptible organisms.


Q: What should I do if my skin irritation seems worse after using Furaderm 0.2%?

Official guidance mandates that the product be stopped immediately if signs of pronounced irritation, sensitization, or superinfection appear. Official patient guidance states that medical advice should be sought if the skin condition does not improve or appears to become worse.


Q: What is the average duration of treatment with Furaderm 0.2% for common conditions?

The typical duration of treatment cited in regulatory documentation is between 7 and 14 days. The full prescribed course of therapy is generally directed to be completed.

Advertisements

How should Furaderm 0.2% be stored and disposed of?

Storage and Disposal Requirements

Official regulatory labeling dictates specific conditions to maintain the stability and integrity of Furaderm 0.2% (Nitrofural Ointment).

Storage Conditions

Requirement Details
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Do not exceed 30 C (86 F) and keep from freezing.
Protection Protect from light and direct sunlight. Preserve the preparation in tight, light-resistant containers to prevent darkening and degradation.
Safety The product must be kept out of the reach of children.

Disposal Instructions

Unused or expired medicine should not be kept. Regulatory guidance advises asking a pharmacist for instruction on proper disposal. If a take-back program is unavailable, official recommendations include removing the medicine from its original container, mixing it with an undesirable substance, and placing the mixture in a sealed bag before disposal in household trash. Personal information on all packaging must be removed or scratched out before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Furaderm 0.2% found in:

A-Z Index: